Critical Care Diagnostics Market
Critical Care Diagnostics Market By Product (Critical Care Glucose Diagnostic Kits, Cardiometabolic Diagnostic Kits, Coagulation Diagnostic Kits), By Test (Hematology Tests, Flow Cytometry), By End User & By Region - Global Insights to 2031
Analysis of Critical Care Diagnostics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Critical Care Diagnostics Market Outlook
Critical care diagnostics market analysis reveals that the global market reached a valuation of US$ 1.1 Bn in 2020, and is anticipated to top US$ 1.7 Bn by 2031, expanding at a CAGR of 5.5%. Demand for hematology tests is projected to rise at a CAGR of 5% across the assessment period of 2021 to 2031.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Key Points Covered in Critical Care Diagnostics Industry Survey:
- Market Estimates and Forecasts (2016 to 2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Growth of Critical Care Diagnostics in 2021
- Key Product Innovations and Regulatory Climate
- Critical Care Diagnostics Kits Market
- Critical Care Diagnostic Test Kits Production Analysis
- COVID-19 Impact on Demand for Critical Care Diagnostics and How to Navigate
- Critical Care Diagnostics and Management
- Recommendation on Key Winning Strategies
Critical Care Diagnostics Demand Analysis from 2016 to 2020 Vs Future Market Outlook for 2021 to 2031
As per Fact.MR - a market research and competitive intelligence provider, the global market for critical care diagnostics was valued at US$ 1.1 Bn in 2020.
Critical care diagnostics is primarily associated with intensive care of patients dealing with life-threatening conditions, which especially require sophisticated invasive monitoring devices alongside other monitoring and life support systems. The need for critical care diagnostic tests is increasing due to growing demand for rapid diagnosis and treatment and especially the rising geriatric population globally.
The market is primarily driven by increasing global prevalence of chronic and lifestyle-related disorders and advancements in diagnostic technologies.
Rising awareness among people for early diagnosis and treatment, rise in the use of data management and connectivity through interoperability to electronic health records (EHR), and rising adoption of telehealth services are the other factors that are expected to drive the market at a 5.5% CAGR across 2021 to 2031.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are Technological Advancements Creating Ample Opportunities for Critical Care Diagnostic Providers?
Technology is evolving rapidly. Critical care refers to meeting the needs of the patients who require immediate attention, due to life-threatening health conditions, where the vital organs of the patient’s body are at the risk of failing. The treatment requires advanced therapeutic, monitoring, and diagnostic technology with the objective of stabilizing the functioning of the organs and improving patient conditions.
Early diagnosis will result in quicker treatment, thus eventually reduces recovery time or chances of the health condition becoming severe. Increased demand for targeted health therapy promotes the need for better diagnostic methods.
Using medical diagnostic techniques that provide quick, effective and reliable is important so that doctors can determine quick treatment measures. This includes critical care diagnostic kits, critical care diagnostic pressure monitors, and life-saving monitoring methods that may be invasive or normal.
Such advances in technology have resulted in greater capability, productivity, sensitivity, specificity, and ultimately, improvement in the clinical care of patients.
What are the Restraints being Faced by Critical Care Diagnostic Product Suppliers?
Increased cost of molecular diagnostics and dearth of skilled labour are factors that are expected to hinder growth of the industry. Long validation processes along with high maintenance costs of critical care diagnostics are acting as restraining factors for the growth of the market.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Region Offers the Largest Opportunity for Critical Care Diagnostics?
North America accounts for around 50% of the global market share for critical care diagnostics. North America has been witnessing stable growth, but with substantial regional variations.
The need for upgrading the technology remains vital for critical care diagnostics and management. This factor is accompanied by the high cost of a long hospital stay, which involves an operating room procedure. The hospital costs by themselves are very high. The high healthcare expenditure, better infrastructure, and additional involvement by the government are expected to drive the growth of the market in North America.
Furthermore, technological advancements increased access to health care services, and entry of new manufacturers are other factors likely to fuel the market in the region during the forecast period.
Other regional markets that are expected to perform well over the coming years include the Canada critical care diagnostics kits market and the U.K. critical care hematology diagnostics market.
Country-wise Analysis
What is the Critical Care Diagnostics Demand Outlook for the U.S.?
The critical care diagnostics market in the U.S. was valued at around US$ 290 Mn in 2020. According to the Health Library, it is estimated that around 84 Mn people in the U.S. suffer from some form of cardiovascular disease, causing around 2,200 deaths a day, averaging one death every 40 seconds.
Hospitals in the U.S. have made substantial investments in the physical infrastructure of their operating rooms. More than 60% of revenue generated from hospitals in the United States come from activities in the operating room of an average hospital.
Why is the Critical Care Diagnostics Industry Flourishing in China?
China is forecast to reach a projected market size of around US$ 320 Mn by 2031. New health reforms implemented by the government in China have expanded the insurance coverage of patients and improved the country’s primary healthcare system, further aiding the growth of the CCD market in Asia Pacific.
Increasing geriatric population, growing number of intensive care specialized hospitals, and improved healthcare infrastructure, presence of regional and international market players, and massive investments in R&D across China are expected to contribute notably toward the country’s market in the upcoming years.
China spends 6% of its GDP on healthcare, according to estimates, and its critical care diagnosis equipment market has grown by double digits for the previous three decades. An increase in the incidences of cardiovascular diseases, demand for critical care diagnostic in ICUs, and the growing adoption of critical care diagnostic devices as part of the treatment of diseases are some of the key factors that have grown the demand for critical care diagnostics in China.
Category-wise Insights
Why is Demand for Critical Care Diagnostics High for Use in Emergency Rooms?
Public demand for emergency rooms, where critically ill patients are recommended, is witnessing a steady rise. The survival rate of critically ill patients in the emergency department is directly related to the advancement of early recognition and treatment of diseases.
According to the recent article of 2017 published in Science Daily by the University of Maryland, the percentage of critical care delivered by the emergency department increased significantly, with nearly half of all the medical care in the United States being delivered by the emergency department.
According to the U.S. Department of Health and Human Services, in 2017, around 18.6 % of adults in the United States had one or more emergency department visits during the preceding 12 months. Moreover, A similar pattern of the increasing number of emergency rooms can be observed in the European countries, whereas, the numbers vary considerably in the emerging economies, such as India, China, and Japan.
Moreover, growing burden of injuries due to accidents and chronic diseases owing to an ageing population is projected to fuel POC critical care market growth over the forecast period.
Why is Demand for Hematology Tests High in the Market for Critical Care Diagnostics?
Hematology tests accounted for a share of 40% in the market. Hematology involves the study of the blood, in particular how blood can affect overall health or disease. Hematology tests include tests on the blood, blood proteins and blood-producing organs.
These tests can evaluate a variety of blood conditions including infection, anemia, inflammation, hemophilia, blood-clotting disorders, leukemia and the body’s response to chemotherapy treatments. Tests may be routine and regular, or they may be called upon to diagnose serious conditions in urgent situations. In many cases, the results of a blood test can give an accurate assessment of body conditions and how internal or external influences may affect a patient’s health.
What Has Been the Impact of COVID-19 on Sales of Critical Care Diagnostic Products?
Implementation of lockdowns and transport bans due to the COVID-19 pandemic has caused disruptions in all sectors, including the critical care diagnostics market. Lack of raw materials has caused a slowdown in the production of medical equipment.
COVID-19 is an incomparable global public health emergency that has affected sales of critical care pregnancy & fertility testing kits and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward.
Many medical equipment must go through a series of pre- and post-market clinical investigations before receiving market authorization certificates. Medical and healthcare departments are operating at full capacity to treat patients as the COVID-19 pandemic spreads. This has led to advancements in technologies and products being used in healthcare. 2021 is projected to be better, with the market regaining its original traction by 2022.
Competitive Landscape
Key players in the global critical care diagnostics market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies to enhance their market presence.
Critical care diagnostics kits manufacturers and critical care diagnostic pressure monitors suppliers are getting involved with government initiations through funding and collaborations, which can help the acute care diagnostics market to garner significant growth.
New strategies being adopted by critical care diagnostics kit manufacturers in Germany and those by Mexico critical care diagnostic pressure monitor suppliers are also expected to aid global market expansion.
Critical Care Diagnostics Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 1.1 Billion |
| Market forecast value in 2031 | USD 1.7 Billion |
| Growth Rate | CAGR of 5.5% from 2021 to 2031 |
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | US$ Mn for Value, ‘000 Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; MEA |
| Key Countries Covered | U.S., Canada, Germany, U.K., France, Spain, Italy, Russia, China, Japan, South Korea, India, Australia, Brazil, Mexico, Argentina, GCC, South Africa |
| Key Market Segments Covered | Product, Test, End User, Region |
| Key Companies Profiled | Abbott Laboratories; Alere, Inc.; Bayer Healthcare AG; Beckman Coulter, Inc.; Becton, Dickinson & Co.; BioMerieux, Inc.; Bio-Rad Laboratories, Inc.; Biosensors Japan Co., Ltd.; Chembio Diagnostic Systems, Inc.; EKF Diagnostics Holdings PLC; Nanomix, Inc.; Nova Biomedical Corporation; Roche Diagnostics (Schweiz) AG; Siemens Healthineers; Sysmex Corporation |
| Pricing | Available upon Request |
Key Market Segments in Critical Care Diagnostics Industry Research
-
By Product :
- Glucose Diagnostic Kits
- Cardiometabolic Diagnostic Kits
- Infectious Disease Testing Kits
- Coagulation Diagnostic Kits
- Cancer Markers Testing Kits
- Hematology Testing Kits
- Pregnancy and Fertility Testing Kits
-
By Test :
- Routine and Special Chemistry Diagnostics
- Flow Cytometry Diagnostics
- Hematology Tests
- Immunoproteins Diagnostics
- Microbial and Infectious Diseases Diagnostics
- Diagnostic Nucleic Acid Amplification Tests
- Coagulation Diagnostics Tests
-
By End User :
- Operating Rooms
- Emergency Rooms
- Intensive Care Units
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 6. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, By Test
- 6.1. Routine and Special Chemistry
- 6.2. Flow Cytometry
- 6.3. Hematology Tests
- 6.4. Immunoproteins
- 6.5. Microbial and Infectious Diseases
- 6.6. Nucleic Acid Amplification Tests
- 6.7. Coagulation Tests
- 7. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Product
- 7.1. Glucose Diagnostic Kits
- 7.2. Cardiometabolic Diagnostic Kits
- 7.3. Infectious Disease Testing Kits
- 7.4. Coagulation Diagnostic Kits
- 7.5. Cancer Markers Testing Kits
- 7.6. Hematology Testing Kits
- 7.7. Pregnancy and Fertility Testing Kits
- 8. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User
- 8.1. Operating Rooms
- 8.2. Emergency Rooms
- 8.3. Intensive Care Units
- 9. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 11. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 12. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 13. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 14. South Asia & Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 15. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Abbott Laboratories
- 17.2. Alere, Inc.
- 17.3. Bayer Healthcare AG
- 17.4. Beckman Coulter, Inc.
- 17.5. Becton, Dickinson & Co.
- 17.6. BioMerieux, Inc.
- 17.7. Bio-Rad Laboratories, Inc.
- 17.8. Biosensors Japan Co., Ltd.
- 17.9. Chembio Diagnostic Systems, Inc.
- 17.10. EKF Diagnostics Holdings PLC
- 17.11. Nanomix, Inc.
- 17.12. Nova Biomedical Corporation
- 17.13. Roche Diagnostics (Schweiz) AG
- 17.14. Siemens Healthineers
- 17.15. Sysmex Corporation
- 18. Assumptions And Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Analysis, by Test, 2016 to 2020
Table 2: Global Market Value (US$ Mn) Analysis, by Test, 2021 to 2031
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Test, 2021 to 2031
Table 4: Global Market Value (US$ Mn) Analysis, by Product, 2016 to 2020
Table 5: Global Market Value (US$ Mn) Analysis, by Product, 2021 to 2031
Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2021 to 2031
Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2016 to 2020
Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2021 to 2031
Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2031
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2016 to 2020
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2021 to 2031
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2021 to 2031
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2016 to 2020
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2021 to 2031
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2031
Table 16: North America Market Value (US$ Mn) Analysis, by Test, 2016 to 2020
Table 17: North America Market Value (US$ Mn) Analysis, by Test, 2021 to 2031
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Test, 2021 to 2031
Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2016 to 2020
Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2021 to 2031
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2021 to 2031
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2016 to 2020
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2021 to 2031
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2031
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2016 to 2020
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2021 to 2031
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2031
Table 28: Latin America Market Value (US$ Mn) Analysis, by Test, 2016 to 2020
Table 29: Latin America Market Value (US$ Mn) Analysis, by Test, 2021 to 2031
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Test, 2021 to 2031
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2016 to 2020
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2021 to 2031
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2021 to 2031
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2016 to 2020
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2021 to 2031
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2031
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2016 to 2020
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2021 to 2031
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2031
Table 40: Europe Market Value (US$ Mn) Analysis, by Test, 2016 to 2020
Table 41: Europe Market Value (US$ Mn) Analysis, by Test, 2021 to 2031
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Test, 2021 to 2031
Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2016 to 2020
Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2021 to 2031
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2021 to 2031
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2016 to 2020
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2021 to 2031
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2031
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2016 to 2020
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2021 to 2031
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2031
Table 52: East Asia Market Value (US$ Mn) Analysis, by Test, 2016 to 2020
Table 53: East Asia Market Value (US$ Mn) Analysis, by Test, 2021 to 2031
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Test, 2021 to 2031
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2016 to 2020
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2021 to 2031
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2021 to 2031
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2016 to 2020
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2021 to 2031
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2031
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2016 to 2020
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2021 to 2031
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2031
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Test, 2016 to 2020
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Test, 2021 to 2031
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Test, 2021 to 2031
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2016 to 2020
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2021 to 2031
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2021 to 2031
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2016 to 2020
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2021 to 2031
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2031
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2016 to 2020
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2021 to 2031
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2021 to 2031
Table 76: MEA Market Value (US$ Mn) Analysis, by Test, 2016 to 2020
Table 77: MEA Market Value (US$ Mn) Analysis, by Test, 2021 to 2031
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Test, 2021 to 2031
Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2016 to 2020
Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2021 to 2031
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2021 to 2031
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2016 to 2020
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2021 to 2031
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2021 to 2031
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) Historical Analysis, 2016 to 2020
Figure 2: Global Market Value (US$ Mn) Forecast and Analysis, 2021 to 2031
Figure 3: Global Market Value Y-o-Y Growth and Forecast, 2016 to 2031
Figure 4: Global Market Incremental $ Opportunity, 2021 to 2031
Figure 5: Global Market Share and BPS Analysis by Test, 2021 & 2031
Figure 6: Global Market Y-o-Y Growth Projections by Test, 2021 to 2031
Figure 7: Global Market Attractiveness Analysis by Test, 2021 to 2031
Figure 8: Global Market Share and BPS Analysis by Product, 2021 & 2031
Figure 9: Global Market Y-o-Y Growth Projections by Product, 2021 to 2031
Figure 10: Global Market Attractiveness Analysis by Product, 2021 to 2031
Figure 11: Global Market Share and BPS Analysis by End User, 2021 & 2031
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2021 to 2031
Figure 13: Global Market Attractiveness Analysis by End User, 2021 to 2031
Figure 14: Global Market Share and BPS Analysis by Region, 2021 & 2031
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2021 to 2031
Figure 16: Global Market Attractiveness Analysis by Region, 2021 to 2031
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2016 to 2020
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2021 to 2031
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2016 to 2031
Figure 20: North America Market Incremental $ Opportunity, 2021 to 2031
Figure 21: North America Market Share Analysis by Country, 2021 & 2031
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2021 to 2031
Figure 23: North America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 24: North America Market Share and BPS Analysis by Test, 2021 & 2031
Figure 25: North America Market Y-o-Y Growth Projections by Test, 2021 to 2031
Figure 26: North America Market Attractiveness Analysis by Test, 2021 to 2031
Figure 27: North America Market Share and BPS Analysis by Product, 2021 & 2031
Figure 28: North America Market Y-o-Y Growth Projections by Product, 2021 to 2031
Figure 29: North America Market Attractiveness Analysis by Product, 2021 to 2031
Figure 30: North America Market Share and BPS Analysis by End User, 2021 & 2031
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2021 to 2031
Figure 32: North America Market Attractiveness Analysis by End User, 2021 to 2031
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2016 to 2020
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2021 to 2031
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2016 to 2031
Figure 36: Latin America Market Incremental $ Opportunity, 2021 to 2031
Figure 37: Latin America Market Share Analysis by Country, 2021 & 2031
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2021 to 2031
Figure 39: Latin America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 40: Latin America Market Share and BPS Analysis by Test, 2021 & 2031
Figure 41: Latin America Market Y-o-Y Growth Projections by Test, 2021 to 2031
Figure 42: Latin America Market Attractiveness Analysis by Test, 2021 to 2031
Figure 43: Latin America Market Share and BPS Analysis by Product, 2021 & 2031
Figure 44: Latin America Market Y-o-Y Growth Projections by Product, 2021 to 2031
Figure 45: Latin America Market Attractiveness Analysis by Product, 2021 to 2031
Figure 46: Latin America Market Share and BPS Analysis by End User, 2021 & 2031
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2021 to 2031
Figure 48: Latin America Market Attractiveness Analysis by End User, 2021 to 2031
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2016 to 2020
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2021 to 2031
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2016 to 2031
Figure 52: Europe Market Incremental $ Opportunity, 2021 to 2031
Figure 53: Europe Market Share Analysis by Country, 2021 & 2031
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2021 to 2031
Figure 55: Europe Market Attractiveness Analysis by Country, 2021 to 2031
Figure 56: Europe Market Share and BPS Analysis by Test, 2021 & 2031
Figure 57: Europe Market Y-o-Y Growth Projections by Test, 2021 to 2031
Figure 58: Europe Market Attractiveness Analysis by Test, 2021 to 2031
Figure 59: Europe Market Share and BPS Analysis by Product, 2021 & 2031
Figure 60: Europe Market Y-o-Y Growth Projections by Product, 2021 to 2031
Figure 61: Europe Market Attractiveness Analysis by Product, 2021 to 2031
Figure 62: Europe Market Share and BPS Analysis by End User, 2021 & 2031
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2021 to 2031
Figure 64: Europe Market Attractiveness Analysis by End User, 2021 to 2031
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2016 to 2020
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2021 to 2031
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2016 to 2031
Figure 68: East Asia Market Incremental $ Opportunity, 2021 to 2031
Figure 69: East Asia Market Share Analysis by Country, 2021 & 2031
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2021 to 2031
Figure 71: East Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 72: East Asia Market Share and BPS Analysis by Test, 2021 & 2031
Figure 73: East Asia Market Y-o-Y Growth Projections by Test, 2021 to 2031
Figure 74: East Asia Market Attractiveness Analysis by Test, 2021 to 2031
Figure 75: East Asia Market Share and BPS Analysis by Product, 2021 & 2031
Figure 76: East Asia Market Y-o-Y Growth Projections by Product, 2021 to 2031
Figure 77: East Asia Market Attractiveness Analysis by Product, 2021 to 2031
Figure 78: East Asia Market Share and BPS Analysis by End User, 2021 & 2031
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2021 to 2031
Figure 80: East Asia Market Attractiveness Analysis by End User, 2021 to 2031
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2016 to 2020
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2021 to 2031
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2016 to 2031
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2021 to 2031
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2021 & 2031
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2021 to 2031
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2021 to 2031
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Test, 2021 & 2031
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Test, 2021 to 2031
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Test, 2021 to 2031
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product, 2021 & 2031
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product, 2021 to 2031
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product, 2021 to 2031
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2021 & 2031
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2021 to 2031
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2021 to 2031
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2016 to 2020
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2021 to 2031
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2016 to 2031
Figure 100: MEA Market Incremental $ Opportunity, 2021 to 2031
Figure 101: MEA Market Share Analysis by Country, 2021 & 2031
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2021 to 2031
Figure 103: MEA Market Attractiveness Analysis by Country, 2021 to 2031
Figure 104: MEA Market Share and BPS Analysis by Test, 2021 & 2031
Figure 105: MEA Market Y-o-Y Growth Projections by Test, 2021 to 2031
Figure 106: MEA Market Attractiveness Analysis by Test, 2021 to 2031
Figure 107: MEA Market Share and BPS Analysis by Product, 2021 & 2031
Figure 108: MEA Market Y-o-Y Growth Projections by Product, 2021 to 2031
Figure 109: MEA Market Attractiveness Analysis by Product, 2021 to 2031
Figure 110: MEA Market Share and BPS Analysis by End User, 2021 & 2031
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2021 to 2031
Figure 112: MEA Market Attractiveness Analysis by End User, 2021 to 2031
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current global market valuation of critical care diagnostics?
The global critical care diagnostics market is currently worth more than US$ 1.1 Bn.
At what CAGR did sales of critical care diagnostic products increase over the last 5 years?
From 2016 to 2020, sales of critical care diagnostic products increased at around 3% CAGR.
What are the key driving factors for demand growth of critical care diagnostics?
Increasing aging population and chronic health concerns are factors driving demand for critical care diagnostics.
Which region is expected to offer growth opportunities for vendors offering critical care diagnostics?
North America accounts for over 50% revenue share for critical care diagnostics.
At what rate are critical care diagnostic products sales expected to grow in Germany?
Sales of critical care diagnostic products in Germany will most likely flourish at a CAGR of 3.5% over the next ten years.
Which are some prominent critical care diagnostic product manufacturers?
Abbott Laboratories, Alere, Inc., Bayer Healthcare AG, and Beckman Coulter, Inc. are renowned critical care diagnostic product suppliers.
Which type of critical care diagnostic test dominates the global market?
Hematology tests accounted for a share of 40% in the market.
Which are the top 5 countries driving demand for critical care diagnostics?
The U.S., U.K, China, India, and Japan are the top 5 countries driving demand for critical care diagnostics.
How much is the global critical care diagnostics market expected to be worth by 2031?
The global market is expected to reach a value of above US$ 1.7 Bn by the end of 2031.
Critical Care Diagnostics Market